Utility of contrast enhanced intraoperative ultrasound using Sonazoid for patients with hepatocellular carcinoma

Utility of contrast enhanced intraoperative ultrasound using Sonazoid for patients with hepatocellular carcinoma - Contrast enhanced intraoperative ultrasound using Sonazoid for hepatocellular carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003046

Enrollment

200

Registered

2010-01-16

Start date

2008-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Contrast enhanced intraoperative ultrasound using Sonazoid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing surgery for hepatocellular carcinoma

Exclusion criteria

Exclusion criteria: 1. Cardiac failure 2. Allergy against egg

Design outcomes

Primary

Measure	Time frame
1. Diagnostic ability to differentiate new lesions detected during conventional fundamental intraoperative ultrasound. 2. Frequency to find new hepatocellular carcinoma solely by contrast enhanced intraoperative ultrasound.	—

Secondary

Measure	Time frame
Safety of contrast enhanced intraoperative ultrasound using Sonazoid.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026